Pharmaceutical and biomedical applications of liquid chromatography:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York
Pergamon
1994
|
| Ausgabe: | 1st ed |
| Schriftenreihe: | Progress in pharmaceutical and biomedical analysis
v. 1 |
| Schlagworte: | |
| Online-Zugang: | FAW01 Volltext |
| Beschreibung: | Includes bibliographical references and index This volume reflects the changes that have taken place in the pharmaceutical industry over the last ten years, most notably the increased importance attached to the question of chirality, the growing influence of biotechnology and the need for more rigorous documentation and validation of analytical methods and procedures. The first part of this book deals with the application of new technology to pharmaceutical and biomedical analysis, reflecting the present needs for increased speed, sensitivity and selectivity in the analysis of drugs. The second chapter provides an overview of capillary electophoresis, which represents one of the most inportant analytical developments to impact directly on pharmaceutical development in recent years. Although not a chromatographic technique, capillary electrophoresis was considered too important to be ignored. Over the last 25 years, liquid chromatography has grown into a mature analytical technique and many of the fundamental issues concerned with retention and separation are well defined. The practitioners of modern liquid chromatography spend as much time in the development of techniques for sampling handling and automation as they do in the development of the separation. Therefore, Part Two of this book describes some of the recent advances in the areas of sample handling and the isolation of compounds from biological samples, including solid phase extraction, restricted access media for direct injection, coupled column technology and microdialysis. Similarily, Part Three contains two chapters concerned with liquid chromatographic methods for the isolation of drug substances, peptides and proteins from other complex media. The pharmaceutical industry and the process of drug development are highly regulated and the increasing importance that the regulatory authorities attach to validation has had a significant impact on the analytical techniques used for the analysis of drugs. Although this has increased the workload of analysts in the pharmaceutical industry, it has also improved the quality of analytical methods used in the support of investigational and new drug applications as well as the quality of methods published more recently in the literature. Consequently, Part Four of this volume describes approaches to the optimization and validation of liquid chromatography methods for the analysis of drugs in the bulk form, in pharmaceutical formulations and biological fluids |
| Beschreibung: | 1 Online-Ressource (x, 379 pages :) |
| ISBN: | 008041009X 0080984541 9780080410098 9780080984544 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV042308185 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 150129s1994 |||| o||u| ||||||eng d | ||
| 020 | |a 008041009X |9 0-08-041009-X | ||
| 020 | |a 0080984541 |c electronic bk. |9 0-08-098454-1 | ||
| 020 | |a 9780080410098 |9 978-0-08-041009-8 | ||
| 020 | |a 9780080984544 |c electronic bk. |9 978-0-08-098454-4 | ||
| 035 | |a (OCoLC)834624260 | ||
| 035 | |a (DE-599)BVBBV042308185 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 | ||
| 082 | 0 | |a 615/.1901 |2 20 | |
| 245 | 1 | 0 | |a Pharmaceutical and biomedical applications of liquid chromatography |c edited by C.M. Riley, W.J. Lough, I.W. Wainer |
| 250 | |a 1st ed | ||
| 264 | 1 | |a New York |b Pergamon |c 1994 | |
| 300 | |a 1 Online-Ressource (x, 379 pages :) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Progress in pharmaceutical and biomedical analysis |v v. 1 | |
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a This volume reflects the changes that have taken place in the pharmaceutical industry over the last ten years, most notably the increased importance attached to the question of chirality, the growing influence of biotechnology and the need for more rigorous documentation and validation of analytical methods and procedures. The first part of this book deals with the application of new technology to pharmaceutical and biomedical analysis, reflecting the present needs for increased speed, sensitivity and selectivity in the analysis of drugs. The second chapter provides an overview of capillary electophoresis, which represents one of the most inportant analytical developments to impact directly on pharmaceutical development in recent years. Although not a chromatographic technique, capillary electrophoresis was considered too important to be ignored. | ||
| 500 | |a Over the last 25 years, liquid chromatography has grown into a mature analytical technique and many of the fundamental issues concerned with retention and separation are well defined. The practitioners of modern liquid chromatography spend as much time in the development of techniques for sampling handling and automation as they do in the development of the separation. Therefore, Part Two of this book describes some of the recent advances in the areas of sample handling and the isolation of compounds from biological samples, including solid phase extraction, restricted access media for direct injection, coupled column technology and microdialysis. Similarily, Part Three contains two chapters concerned with liquid chromatographic methods for the isolation of drug substances, peptides and proteins from other complex media. | ||
| 500 | |a The pharmaceutical industry and the process of drug development are highly regulated and the increasing importance that the regulatory authorities attach to validation has had a significant impact on the analytical techniques used for the analysis of drugs. Although this has increased the workload of analysts in the pharmaceutical industry, it has also improved the quality of analytical methods used in the support of investigational and new drug applications as well as the quality of methods published more recently in the literature. Consequently, Part Four of this volume describes approaches to the optimization and validation of liquid chromatography methods for the analysis of drugs in the bulk form, in pharmaceutical formulations and biological fluids | ||
| 650 | 7 | |a MEDICAL / Drug Guides |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Nursing / Pharmacology |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Pharmacy |2 bisacsh | |
| 650 | 7 | |a Biomolecules / Analysis |2 fast | |
| 650 | 7 | |a Drugs / Analysis |2 fast | |
| 650 | 7 | |a Liquid chromatography |2 fast | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Drugs |x Analysis | |
| 650 | 4 | |a Liquid chromatography | |
| 650 | 4 | |a Biomolecules |x Analysis | |
| 650 | 0 | 7 | |a Flüssigkeitschromatographie |0 (DE-588)4017622-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelanalyse |0 (DE-588)4003116-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Biomolekül |0 (DE-588)4135124-1 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Flüssigkeitschromatographie |0 (DE-588)4017622-8 |D s |
| 689 | 0 | 1 | |a Biomolekül |0 (DE-588)4135124-1 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 689 | 1 | 0 | |a Arzneimittelanalyse |0 (DE-588)4003116-0 |D s |
| 689 | 1 | 1 | |a Flüssigkeitschromatographie |0 (DE-588)4017622-8 |D s |
| 689 | 1 | |8 2\p |5 DE-604 | |
| 700 | 1 | |a Riley, Christopher M. |e Sonstige |4 oth | |
| 700 | 1 | |a Lough, W. J. |e Sonstige |4 oth | |
| 700 | 1 | |a Wainer, Irving W. |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/book/9780080410098 |x Verlag |3 Volltext |
| 912 | |a ZDB-33-ESD | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-027745177 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u http://www.sciencedirect.com/science/book/9780080410098 |l FAW01 |p ZDB-33-ESD |q FAW_PDA_ESD |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804152894312677376 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV042308185 |
| collection | ZDB-33-ESD |
| ctrlnum | (OCoLC)834624260 (DE-599)BVBBV042308185 |
| dewey-full | 615/.1901 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.1901 |
| dewey-search | 615/.1901 |
| dewey-sort | 3615 41901 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 1st ed |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05130nmm a2200697zcb4500</leader><controlfield tag="001">BV042308185</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">150129s1994 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">008041009X</subfield><subfield code="9">0-08-041009-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0080984541</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-08-098454-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780080410098</subfield><subfield code="9">978-0-08-041009-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780080984544</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-08-098454-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)834624260</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042308185</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.1901</subfield><subfield code="2">20</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmaceutical and biomedical applications of liquid chromatography</subfield><subfield code="c">edited by C.M. Riley, W.J. Lough, I.W. Wainer</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Pergamon</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (x, 379 pages :)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Progress in pharmaceutical and biomedical analysis</subfield><subfield code="v">v. 1</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">This volume reflects the changes that have taken place in the pharmaceutical industry over the last ten years, most notably the increased importance attached to the question of chirality, the growing influence of biotechnology and the need for more rigorous documentation and validation of analytical methods and procedures. The first part of this book deals with the application of new technology to pharmaceutical and biomedical analysis, reflecting the present needs for increased speed, sensitivity and selectivity in the analysis of drugs. The second chapter provides an overview of capillary electophoresis, which represents one of the most inportant analytical developments to impact directly on pharmaceutical development in recent years. Although not a chromatographic technique, capillary electrophoresis was considered too important to be ignored. </subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Over the last 25 years, liquid chromatography has grown into a mature analytical technique and many of the fundamental issues concerned with retention and separation are well defined. The practitioners of modern liquid chromatography spend as much time in the development of techniques for sampling handling and automation as they do in the development of the separation. Therefore, Part Two of this book describes some of the recent advances in the areas of sample handling and the isolation of compounds from biological samples, including solid phase extraction, restricted access media for direct injection, coupled column technology and microdialysis. Similarily, Part Three contains two chapters concerned with liquid chromatographic methods for the isolation of drug substances, peptides and proteins from other complex media. </subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">The pharmaceutical industry and the process of drug development are highly regulated and the increasing importance that the regulatory authorities attach to validation has had a significant impact on the analytical techniques used for the analysis of drugs. Although this has increased the workload of analysts in the pharmaceutical industry, it has also improved the quality of analytical methods used in the support of investigational and new drug applications as well as the quality of methods published more recently in the literature. Consequently, Part Four of this volume describes approaches to the optimization and validation of liquid chromatography methods for the analysis of drugs in the bulk form, in pharmaceutical formulations and biological fluids</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Drug Guides</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Nursing / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacy</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biomolecules / Analysis</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs / Analysis</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Liquid chromatography</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Analysis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Liquid chromatography</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biomolecules</subfield><subfield code="x">Analysis</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Flüssigkeitschromatographie</subfield><subfield code="0">(DE-588)4017622-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelanalyse</subfield><subfield code="0">(DE-588)4003116-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biomolekül</subfield><subfield code="0">(DE-588)4135124-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Flüssigkeitschromatographie</subfield><subfield code="0">(DE-588)4017622-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Biomolekül</subfield><subfield code="0">(DE-588)4135124-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Arzneimittelanalyse</subfield><subfield code="0">(DE-588)4003116-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Flüssigkeitschromatographie</subfield><subfield code="0">(DE-588)4017622-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Riley, Christopher M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lough, W. J.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wainer, Irving W.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/book/9780080410098</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-33-ESD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027745177</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://www.sciencedirect.com/science/book/9780080410098</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-33-ESD</subfield><subfield code="q">FAW_PDA_ESD</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV042308185 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T01:17:58Z |
| institution | BVB |
| isbn | 008041009X 0080984541 9780080410098 9780080984544 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027745177 |
| oclc_num | 834624260 |
| open_access_boolean | |
| owner | DE-1046 |
| owner_facet | DE-1046 |
| physical | 1 Online-Ressource (x, 379 pages :) |
| psigel | ZDB-33-ESD ZDB-33-ESD FAW_PDA_ESD |
| publishDate | 1994 |
| publishDateSearch | 1994 |
| publishDateSort | 1994 |
| publisher | Pergamon |
| record_format | marc |
| series2 | Progress in pharmaceutical and biomedical analysis |
| spelling | Pharmaceutical and biomedical applications of liquid chromatography edited by C.M. Riley, W.J. Lough, I.W. Wainer 1st ed New York Pergamon 1994 1 Online-Ressource (x, 379 pages :) txt rdacontent c rdamedia cr rdacarrier Progress in pharmaceutical and biomedical analysis v. 1 Includes bibliographical references and index This volume reflects the changes that have taken place in the pharmaceutical industry over the last ten years, most notably the increased importance attached to the question of chirality, the growing influence of biotechnology and the need for more rigorous documentation and validation of analytical methods and procedures. The first part of this book deals with the application of new technology to pharmaceutical and biomedical analysis, reflecting the present needs for increased speed, sensitivity and selectivity in the analysis of drugs. The second chapter provides an overview of capillary electophoresis, which represents one of the most inportant analytical developments to impact directly on pharmaceutical development in recent years. Although not a chromatographic technique, capillary electrophoresis was considered too important to be ignored. Over the last 25 years, liquid chromatography has grown into a mature analytical technique and many of the fundamental issues concerned with retention and separation are well defined. The practitioners of modern liquid chromatography spend as much time in the development of techniques for sampling handling and automation as they do in the development of the separation. Therefore, Part Two of this book describes some of the recent advances in the areas of sample handling and the isolation of compounds from biological samples, including solid phase extraction, restricted access media for direct injection, coupled column technology and microdialysis. Similarily, Part Three contains two chapters concerned with liquid chromatographic methods for the isolation of drug substances, peptides and proteins from other complex media. The pharmaceutical industry and the process of drug development are highly regulated and the increasing importance that the regulatory authorities attach to validation has had a significant impact on the analytical techniques used for the analysis of drugs. Although this has increased the workload of analysts in the pharmaceutical industry, it has also improved the quality of analytical methods used in the support of investigational and new drug applications as well as the quality of methods published more recently in the literature. Consequently, Part Four of this volume describes approaches to the optimization and validation of liquid chromatography methods for the analysis of drugs in the bulk form, in pharmaceutical formulations and biological fluids MEDICAL / Drug Guides bisacsh MEDICAL / Nursing / Pharmacology bisacsh MEDICAL / Pharmacology bisacsh MEDICAL / Pharmacy bisacsh Biomolecules / Analysis fast Drugs / Analysis fast Liquid chromatography fast Medizin Drugs Analysis Liquid chromatography Biomolecules Analysis Flüssigkeitschromatographie (DE-588)4017622-8 gnd rswk-swf Arzneimittelanalyse (DE-588)4003116-0 gnd rswk-swf Biomolekül (DE-588)4135124-1 gnd rswk-swf Flüssigkeitschromatographie (DE-588)4017622-8 s Biomolekül (DE-588)4135124-1 s 1\p DE-604 Arzneimittelanalyse (DE-588)4003116-0 s 2\p DE-604 Riley, Christopher M. Sonstige oth Lough, W. J. Sonstige oth Wainer, Irving W. Sonstige oth http://www.sciencedirect.com/science/book/9780080410098 Verlag Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Pharmaceutical and biomedical applications of liquid chromatography MEDICAL / Drug Guides bisacsh MEDICAL / Nursing / Pharmacology bisacsh MEDICAL / Pharmacology bisacsh MEDICAL / Pharmacy bisacsh Biomolecules / Analysis fast Drugs / Analysis fast Liquid chromatography fast Medizin Drugs Analysis Liquid chromatography Biomolecules Analysis Flüssigkeitschromatographie (DE-588)4017622-8 gnd Arzneimittelanalyse (DE-588)4003116-0 gnd Biomolekül (DE-588)4135124-1 gnd |
| subject_GND | (DE-588)4017622-8 (DE-588)4003116-0 (DE-588)4135124-1 |
| title | Pharmaceutical and biomedical applications of liquid chromatography |
| title_auth | Pharmaceutical and biomedical applications of liquid chromatography |
| title_exact_search | Pharmaceutical and biomedical applications of liquid chromatography |
| title_full | Pharmaceutical and biomedical applications of liquid chromatography edited by C.M. Riley, W.J. Lough, I.W. Wainer |
| title_fullStr | Pharmaceutical and biomedical applications of liquid chromatography edited by C.M. Riley, W.J. Lough, I.W. Wainer |
| title_full_unstemmed | Pharmaceutical and biomedical applications of liquid chromatography edited by C.M. Riley, W.J. Lough, I.W. Wainer |
| title_short | Pharmaceutical and biomedical applications of liquid chromatography |
| title_sort | pharmaceutical and biomedical applications of liquid chromatography |
| topic | MEDICAL / Drug Guides bisacsh MEDICAL / Nursing / Pharmacology bisacsh MEDICAL / Pharmacology bisacsh MEDICAL / Pharmacy bisacsh Biomolecules / Analysis fast Drugs / Analysis fast Liquid chromatography fast Medizin Drugs Analysis Liquid chromatography Biomolecules Analysis Flüssigkeitschromatographie (DE-588)4017622-8 gnd Arzneimittelanalyse (DE-588)4003116-0 gnd Biomolekül (DE-588)4135124-1 gnd |
| topic_facet | MEDICAL / Drug Guides MEDICAL / Nursing / Pharmacology MEDICAL / Pharmacology MEDICAL / Pharmacy Biomolecules / Analysis Drugs / Analysis Liquid chromatography Medizin Drugs Analysis Biomolecules Analysis Flüssigkeitschromatographie Arzneimittelanalyse Biomolekül |
| url | http://www.sciencedirect.com/science/book/9780080410098 |
| work_keys_str_mv | AT rileychristopherm pharmaceuticalandbiomedicalapplicationsofliquidchromatography AT loughwj pharmaceuticalandbiomedicalapplicationsofliquidchromatography AT wainerirvingw pharmaceuticalandbiomedicalapplicationsofliquidchromatography |